An oral version of semaglutide, sold under the brand name Rybelsus, has been on the market since 2019 but is not approved for weight management and isnt as effective for weight loss as injectable GLP-1s
If you are concerned about your nutritional health, Dr
the specific return process steps
Aroda VR, Edelstein SL, Goldberg RB et al (2016) Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study
These findings dont rule out its use, but they do mean close monitoring matters, especially if you already have heart disease or risk factors
GLP-1 medications may be most appropriate for patients new to weight loss medications seeking proven, well-studied options